Safety Alert

#	Title	Type of news	Date
82	Potential Risk of Tumor Lysis Syndrome Associated with the Use Pazopanib	Precautions	2020-11-09
81	Baricitinib (Olumiant®) and increased risk of diverticulitis: Recommendations for Healthcare Professionals from the SFDA	Precautions	2020-09-02
80	Safety Signal of Hypokalemia associated with the use of Ceftriaxone	Signal	2020-09-07
79	Safety Signal of Molluscum Contagiosum associated with the use of Fingolimod	Signal	2020-09-07
78	Safety Signal of Rhabdomyolysis associated with the use of Pembrolizumab	Signal	2020-09-07
77	Safety Signal of Baricitinib and the Potential Risk of Diverticulitis	Signal	2020-03-25
76	Safety Signal of Cardiac Failure associated with the use of Ibrutinib	Signal	2020-08-02
75	Safety Signal of Skin Cancer associated with the use of Methotrexate	Signal	2020-09-07
74	Switching between Warfarin Brands and The Importance of Close Monitoring of INR	Precautions	2020-06-09
73	Hydroxychloroquine and Chloroquine Alone and in Combination with Azithromycin and Potential Increased Risk of Heart Rhythm Problems	Warning	2020-05-11